178 related articles for article (PubMed ID: 36136036)
1. What do we know about carcinoid heart disease in the present era?
Pęczkowska M; Konsek-Komorowska SJ; Kolasińska-Ćwikła AD; Konka M; Michałowska I; Ćwikła JB
Kardiol Pol; 2022; 80(10):990-1001. PubMed ID: 36136036
[TBL] [Abstract][Full Text] [Related]
2. Carcinoid heart disease in patients with midgut neuroendocrine tumours.
Delhomme C; Walter T; Arangalage D; Suc G; Hentic O; Cachier A; Alkhoder S; François L; Lombard-Bohas C; Iung B; Ruszniewski P; de Mestier L
J Neuroendocrinol; 2023 Apr; 35(4):e13262. PubMed ID: 37005217
[TBL] [Abstract][Full Text] [Related]
3. Update in carcinoid heart disease - the heart of the matter.
Oleinikov K; Korach A; Planer D; Gilon D; Grozinsky-Glasberg S
Rev Endocr Metab Disord; 2021 Sep; 22(3):553-561. PubMed ID: 33443717
[TBL] [Abstract][Full Text] [Related]
4. Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours.
Kostiainen I; Karppinen N; Simonen P; Rosengård-Bärlund M; Lindén R; Tarkkanen M; Gordin D; Rapola J; Schalin-Jäntti C; Matikainen N
Endocrine; 2022 Jun; 77(1):177-187. PubMed ID: 35536452
[TBL] [Abstract][Full Text] [Related]
5. Four decades of experience with carcinoid heart disease: An analysis of 84 patients.
Levy S; Korse CE; de Groot ACA; Meijer RCA; Tesselaar MET; Valk GD
J Neuroendocrinol; 2022 Oct; 34(10):e13199. PubMed ID: 36256859
[TBL] [Abstract][Full Text] [Related]
6. Carcinoid Heart Disease: Pathophysiology, Pathology, Clinical Manifestations, and Management.
Jin C; Sharma AN; Thevakumar B; Majid M; Al Chalaby S; Takahashi N; Tanious A; Arockiam AD; Beri N; Amsterdam EA
Cardiology; 2021; 146(1):65-73. PubMed ID: 33070143
[TBL] [Abstract][Full Text] [Related]
7. Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease.
Zuetenhorst JM; Korse CM; Bonfrer JM; Bakker RH; Taal BG
Br J Cancer; 2004 Jun; 90(11):2073-9. PubMed ID: 15150565
[TBL] [Abstract][Full Text] [Related]
8. Carcinoid Heart Disease: a Review.
Laskaratos FM; Davar J; Toumpanakis C
Curr Oncol Rep; 2021 Mar; 23(4):48. PubMed ID: 33725214
[TBL] [Abstract][Full Text] [Related]
9. Carcinoid Heart Disease Management: A Multi-Disciplinary Collaboration.
Das S; Stockton SS; Hassan SA
Oncologist; 2023 Jul; 28(7):575-583. PubMed ID: 37209415
[TBL] [Abstract][Full Text] [Related]
10. Carcinoid Heart Disease: From Pathophysiology to Treatment--'Something in the Way It Moves'.
Grozinsky-Glasberg S; Grossman AB; Gross DJ
Neuroendocrinology; 2015; 101(4):263-73. PubMed ID: 25871411
[TBL] [Abstract][Full Text] [Related]
11. Carcinoid heart disease.
Palaniswamy C; Frishman WH; Aronow WS
Cardiol Rev; 2012; 20(4):167-76. PubMed ID: 22314145
[TBL] [Abstract][Full Text] [Related]
12. Carcinoid heart disease.
Gustafsson BI; Hauso O; Drozdov I; Kidd M; Modlin IM
Int J Cardiol; 2008 Oct; 129(3):318-24. PubMed ID: 18571250
[TBL] [Abstract][Full Text] [Related]
13. Determination of the optimal echocardiographic scoring system to quantify carcinoid heart disease.
Dobson R; Cuthbertson DJ; Jones J; Valle JW; Keevil B; Chadwick C; Poston GP; Burgess MI
Neuroendocrinology; 2014; 99(2):85-93. PubMed ID: 24603343
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of patients with carcinoid heart disease after valvular surgery.
Manoly I; McAnelly SL; Sriskandarajah S; McLaughlin KE
Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):302-5. PubMed ID: 24812331
[TBL] [Abstract][Full Text] [Related]
15. Managing carcinoid heart disease in patients with neuroendocrine tumors.
Koffas A; Toumpanakis C
Ann Endocrinol (Paris); 2021 Jun; 82(3-4):187-192. PubMed ID: 33321109
[TBL] [Abstract][Full Text] [Related]
16. Carcinoid Heart Disease: A Review.
Hayes AR; Davar J; Caplin ME
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):671-682. PubMed ID: 30098723
[TBL] [Abstract][Full Text] [Related]
17. Chromogranin A (CgA) as a biomarker in carcinoid heart disease and NETG1/G2 neuroendocrine neoplasms of the small intestine (SI-NENs) related carcinoid syndrome.
Konsek-Komorowska SJ; Pęczkowska M; Kolasińska-Ćwikła AD; Konka M; Chrapowicki E; Ćwikła JB
Med Clin (Barc); 2022 Jul; 159(2):85-89. PubMed ID: 34736622
[TBL] [Abstract][Full Text] [Related]
18. Carcinoid heart disease--a hidden complication of neuroendocrine tumours.
Dero I; De Pauw M; Borbath I; Delaunoit T; Demetter P; Demolin G; Hendlisz A; Pattyn P; Pauwels S; Roeyen G; Van Cutsem E; Van Hootegem P; Van Laethem JL; Verslype C; Peeters M
Acta Gastroenterol Belg; 2009; 72(1):34-8. PubMed ID: 19402369
[TBL] [Abstract][Full Text] [Related]
19. Carcinoid Heart Disease: Prognostic Value of 5-Hydroxyindoleacetic Acid Levels and Impact on Survival: A Systematic Literature Review.
Buchanan-Hughes A; Pashley A; Feuilly M; Marteau F; Pritchard DM; Singh S
Neuroendocrinology; 2021; 111(1-2):1-15. PubMed ID: 32097914
[TBL] [Abstract][Full Text] [Related]
20. Real-world treatment patterns, resource use and costs of treating uncontrolled carcinoid syndrome and carcinoid heart disease: a retrospective Swedish study.
Lesén E; Björstad Å; Björholt I; Marlow T; Bollano E; Feuilly M; Marteau F; Welin S; Elf AK; Johanson V
Scand J Gastroenterol; 2018 Dec; 53(12):1509-1518. PubMed ID: 30449217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
